Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOl and etc.
Emerging copper-mediated lethal mechanisms provide cancer therapies, with current research emphasizing precise copper regulation to enhance its dual role in tumor pathology. Here, we presented a bimetallic nanoplatform, HMCuS/Ru/ICG/GOx@9R-P201Ti (HRIG9R), designed to amplify cuproptosis for hepatocellular carcinoma (HCC) therapy. Upon 808 nm near-infrared (NIR) irradiation, the mild photothermal effect enhanced cytotoxic T-cell differentiation. Concurrently, glucose oxidase (GOx) depletes glucose and generats hydrogen peroxide (H2O2), fueling Ru-mediated chemodynamic therapy (CDT) and reducing Cu2+ to toxic Cu+ to potentiate cuproptosis. This synergistic cascade—integrating starvation, CDT, and adenosine triphosphate (ATP) depletion—reprogrammed the tumor immune microenvironment and induced immunogenic cell death (ICD). These findings highlight the HMCuS/Ru/ICG/GOx@9R-P201Ti nanoplatform as a potent strategy to enhance cuproptosis-based anticancer immunotherapy.

This is an open access article under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0, https://creativecommons.org/licenses/by/4.0/).
Comments on this article